ZYRKINUS Trademark

Trademark Overview


On Thursday, June 16, 2016, a trademark application was filed for ZYRKINUS with the United States Patent and Trademark Office. The USPTO has given the ZYRKINUS trademark a serial number of 87073997. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 19, 2024. This trademark is owned by Glaxo Group Limited. The ZYRKINUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; all of the foregoing, excluding pharmaceutical preparations for the treatment of sleep disorders and narcolepsy
zyrkinus

General Information


Serial Number87073997
Word MarkZYRKINUS
Filing DateThursday, June 16, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 19, 2024
Registration Number5235212
Registration DateTuesday, July 4, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; all of the foregoing, excluding pharmaceutical preparations for the treatment of sleep disorders and narcolepsy
Translation of Words in MarkThe wording "ZYRKINUS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, January 19, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 4, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 4, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, May 25, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, March 17, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, March 1, 2017ASSIGNED TO PETITION STAFF
Tuesday, February 7, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, December 15, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 13, 2016ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 7, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, September 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 19, 2016ASSIGNED TO EXAMINER
Wednesday, June 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 20, 2016NEW APPLICATION ENTERED